Injective (INJ) is showing bullish signals as it consolidates above key support near $3.00, suggesting a potential reversal. Recent mainnet upgrades and a $2 million institutional purchase have driven a 35% rally, with the token's price rising from $2.97 to $4.02. The upgrades include proposals to reduce token issuance and increase the burn rate, enhancing the platform's DeFi capabilities. Institutional interest is highlighted by Pineapple Financial's acquisition of $2 million worth of INJ, now holding over 7% of the total supply. Additionally, Korea University has launched its first enterprise validator, staking 369,809 INJ. These developments, alongside a 155% spike in trading volume to $155.4 million, underscore renewed market interest. While analysts are optimistic, predicting potential price targets up to $48, caution is advised due to bearish MACD signals. Injective's market cap stands at approximately $320 million, with room for growth if market conditions improve.